Grzegorz M Popowicz

发表

The p53-MDM2/MDMX axis - A chemotype perspective.

Alexander Dömling, Kareem Khoury, T. Holak, 2011, MedChemComm.

Structural basis for the regulation of insulin-like growth factors by IGF binding proteins.

Robert Huber, Igor Siwanowicz, R. Huber, 2006, Structure.

Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.

Alexander Dömling, Michal Bista, Stuti Srivastava, 2010, Angewandte Chemie.

The structure-based design of Mdm2/Mdmx-p53 inhibitors gets serious.

Alexander Dömling, T. Holak, A. Dömling, 2011, Angewandte Chemie.

Transient protein states in designing inhibitors of the MDM2-p53 interaction.

Alexander Dömling, Michal Bista, Kareem Khoury, 2013, Structure.

Structure of the human Mdmx protein bound to the p53 tumor suppressor transactivation domain

T. Holak, G. Popowicz, A. Czarna, 2008, Cell cycle.

The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.

Robert Huber, Francesc X Aviles, R. Huber, 2005, Journal of molecular biology.

High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx

G. Dubin, T. Holak, G. Popowicz, 2009, Cell cycle.

Structures of low molecular weight inhibitors bound to MDMX and MDM2 reveal new approaches for p53-MDMX/MDM2 antagonist drug discovery

Wei Wang, Alexander Dömling, Kan Wang, 2010, Cell cycle.